European Commission head Ursula von der Leyen said on Friday the EU was in discussions with more companies to secure potential COVID-19 vaccines, as reported in London South East.
She indicated that "the commission has already concluded two advance purchase agreements and it is negotiating five more, and we are in discussions with four more companies."
The EU has so far announced supply deals for the potential vaccines being developed by AstraZeneca and by a partnership between Sanofi and GlaxoSmithKline.
It has also said publicly that it was in advanced negotiations to secure vaccines being developed by Moderna, Johnson & Johnson, CureVac and a partnership between Pfizer and BioNTech.
Meanwhile, a senior EU source recently said the bloc is also in talks with Novavax for a seventh vaccine.
To read more NewsPoints articles, click here.